Age-Related Differences in In-vitro Sensitivity to Inhibition of Human Red Blood Cell Acetylcholinesterase and Plasma Butyrylcholinesterase by the Cholinesterase Inhibitors Physostigmine (PHYS), Pyridostigmine (PYR), Donepezil (DON) and Galantamine (GAL)
Alzheimer’s disease (AD) is a chronic, progressive neurodegenerative disorder, characterized clinically by a progressive loss of memory, cognitive function, ability to care for oneself and psychiatric symptoms. First-line agents for the treatment of AD are ChE inhibitors (DON, GAL), whose modest cli...
Main Author: | Lee, David |
---|---|
Format: | Others |
Published: |
VCU Scholars Compass
2009
|
Subjects: | |
Online Access: | http://scholarscompass.vcu.edu/etd/1937 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=2936&context=etd |
Similar Items
-
Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
by: Ben Seltzer
Published: (2009-12-01) -
Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors
by: Keith D. Green, et al.
Published: (2018-12-01) -
Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes
by: Stane Pajk, et al.
Published: (2020-01-01) -
Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors
by: Zeynep Soyer, et al.
Published: (2017-01-01) -
Acute electrophysiologic consequences of pyridostigmine inhibition of cholinesterase in humans
by: L.I. Zimerman, et al.
Published: (2010-02-01)